LISATA THERAPEUTICS, INC. Intangible Assets, Net (Excluding Goodwill)
LISATA THERAPEUTICS, INC. (LSTA) had Intangible Assets, Net (Excluding Goodwill) of $400.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-06
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $400.00K.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $400.00K.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $400.00K.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $400.00K.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $400.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $400.00K 10-K · filed 2025-02-27 | |
| 2024-09-30 | $400.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $400.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $400.00K 10-K · filed 2024-02-29 | |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $400.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $400.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $400.00K 10-K · filed 2023-03-30 | |
| 2017-03-31 | $2.17M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.31M 10-Q · filed 2017-05-15 | |
| 2016-09-30 | $2.45M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.59M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.74M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.88M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $37.71M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $37.86M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $47.41M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $47.56M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $47.71M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $49.36M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $13.72M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $13.88M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $14.03M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $14.18M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $14.33M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $14.48M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $14.63M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $14.78M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $36.27M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $15.09M 10-K · filed 2013-03-11 | $36.93M 10-K · filed 2012-03-20 |
| 2011-09-30 | $30.46M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $31.19M 10-Q · filed 2011-08-12 | |
| 2011-01-19 | $5.70M 10-K · filed 2013-03-11 | |
| 2010-12-31 | $563.37K 8-K · filed 2012-08-15 | $24.47M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |